Review article · 2026
Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies
Inflammation Research, 75(1), 15 · Published 8 January 2026 · DOI 10.1007/s00011-025-02170-w
In brief
“Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies” is a 2026 review article by Fuyu Yang and 4 co-authors, published in Inflammation Research. OpenAlex counts 4 citations as of 19 November 2026, which puts it in the top 3% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 4
- Most cited in
- 2026 (4)
- Field-weighted impact
- 3.44
- References
- 44
- Authors
- 5
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yang, F., Liu, Y.-C., Wu, M.-Y., Wu, Y., & Hung, C. (2026). Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies. Inflammation Research, 75(1), 15. https://doi.org/10.1007/s00011-025-02170-w
MLA 9
Yang, Fuyu, et al. “Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies.” Inflammation Research, vol. 75, no. 1, 2026, p. 15. https://doi.org/10.1007/s00011-025-02170-w.
Chicago
Yang, Fuyu, Yu-Chang Liu, Min-You Wu, Yao‐Cheng Wu, and Cheng‐Hsien Hung. 2026. “Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies.” Inflammation Research 75 (1): 15. https://doi.org/10.1007/s00011-025-02170-w.
Harvard
Yang, F. et al. (2026) ‘Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies’, Inflammation Research, 75(1), p. 15. doi:10.1007/s00011-025-02170-w.
IEEE
F. Yang, Y.-C. Liu, M.-Y. Wu, Y. Wu, and C. Hung, “Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies,” Inflammation Research, vol. 75, no. 1, p. 15, 2026, doi: 10.1007/s00011-025-02170-w.
BibTeX
@article{yang2026comparison,
title = {{Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies}},
author = {Yang, Fuyu and Liu, Yu-Chang and Wu, Min-You and Wu, Yao‐Cheng and Hung, Cheng‐Hsien},
journal = {Inflammation Research},
year = {2026},
volume = {75},
number = {1},
pages = {15},
doi = {10.1007/s00011-025-02170-w},
url = {https://doi.org/10.1007/s00011-025-02170-w}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- rheumatoid arthritis
- JAK inhibitors
- TNF-alpha inhibitors
- cancer risk
- non-melanoma skin cancer
- drug safety
- real-world data
- comparative effectiveness
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Yang, F., Liu, Y.-C., Wu, M.-Y., Wu, Y., & Hung, C. (2026). Comparison of cancer risks associated with JAK inhibitors and TNF inhibitors treatment in patients with rheumatoid arthritis: a systematic review and meta-analysis of real-world cohort studies. Inflammation Research, 75(1), 15. https://doi.org/10.1007/s00011-025-02170-w
How many times has this paper been cited?
4 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Fuyu Yang, Yu-Chang Liu, Min-You Wu, Yao‐Cheng Wu, Cheng‐Hsien Hung.
What is the DOI of this paper?
10.1007/s00011-025-02170-w, permanently at https://doi.org/10.1007/s00011-025-02170-w. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.